Previous 10 | Next 10 |
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and through our license to Santen Pharmaceutical Co. Ltd., wet age‐...
TRACON Pharmaceuticals Inc. (TCON) Q1 2019 Earnings Conference Call May 14, 2019 16:30 ET Company Participants Charles Theuer - President & CEO Scott Brown - Director, Controller Conference Call Participants Maury Raycroft - Jefferies Jake Colby - BTIG Presentation ...
Tracon (NASDAQ: TCON ): Q1 GAAP EPS of -$0.24 beats by $0.02 . More news on: TRACON Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and through our license to Santen Pharmaceutical Co. Ltd., wet age‐...
SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and, through our license to Santen Pharmaceutical Co. Ltd., wet age-related...
Gainers: Reebonz Holding (NASDAQ: RBZ ) +111% . Castor Maritime (NASDAQ: CTRM ) +43% . Anadarko Petroleum (NYSE: APC ) +33% . Immuron (NASDAQ: IMRN ) +27% . Enlivex Therapeutics (NASDAQ: ENLV ) +17% . Kitov Pharma (NASDAQ: KTOV ) +17% . Renren (NYSE: RENN ) +15% . Summit Wirel...
Reebonz Holding (NASDAQ: RBZ ) -52% . More news on: Reebonz Holding Limited, TRACON Pharmaceuticals, Inc., X4 Pharmaceuticals, Inc., Stocks on the move, Read more ...
TRACON Pharmaceuticals' (NASDAQ: TCON ) Phase 3 TAPPAS trial evaluating TRC105 in combination with Votrient (pazopanib) in patients with advanced or metastatic angiosarcoma was terminated for futility. More news on: TRACON Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the...
SAN DIEGO, April 12, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and, through our license to Santen Pharmaceutical Co. Ltd., wet age-relat...
Fusion Connect (NASDAQ: FSNN ) -82% as audit problems prompt Chapter 11 analyst warning. More news on: Fusion Connect, Inc., Advaxis, Inc., AVEO Pharmaceuticals, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
TRACON Pharmaceuticals Inc. Company Name:
TCON Stock Symbol:
OTCMKTS Market:
TRACON Pharmaceuticals Inc. Website:
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision was made at a special meeting of the board of directors. The board of directors appointed Craig R....
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
A look at the top 10 most actives in the United States American Rebel Holdings Inc. (AREB) rose 60.3% to $0.83355 on volume of 56,112,820 shares DatChat Inc. (DATS) rose 71.2% to $1.78 on volume of 33,845,116 shares Autonomix Medical Inc. (AMIX) rose 97.4% to $1.22 on volume of 33,054,234...